. Author manuscript; available in PMC: 2020 Oct 1.

Published in final edited form as: Neurobiol Dis. 2019 Jun 22;130:104502. doi: 10.1016/j.nbd.2019.104502

Table 1.

Demographics and clinical data.

Variables	Cognitively normal (n = 8)	HAND (n = 39)			Cog. Normal vs HAND		Cog. normal vs ANI vs MND vs HAD
Variables	Cognitively normal (n = 8)	ANI (n=12)	MND (n=14)	HAD (n=13)	p-value (Cog. normal vs HAND; t-test)	Effect Size - Cohen’s d (Cog. norm vs HAND)	p-value (Cog. norm vs ANI, Cog. norm vs MND, Cog. norm vs HAD, ANI vs MND, ANI vs HAD, MND vs HAD; ANOVA)	Effect Size: overall (Cog. Norm vs ANI, Cog. norm vs MND, Cog. Norm vs HAD, ANI vs MND, ANI vs HAD, MND vs HAD)
Demographics
Hispanic ethnicity (%)	57.1	56.3	66.7	77.1	N/A	N/A	N/A	N/A
Sex (f/m)	0/8	3/9	2/12	1/12	N/A	N/A	N/A	N/A
Years of education	12.0 ± 2.09	13.41 ± 2.67	12.0 ± 3.37	9.0 ± 4.37	0.39	0.07	0.09 (> 0.99, > 0.99, 0.25, > 0.99, 0.12, 0.4)	0.51 (0.14, 0.00, 0.3, 0.16, 0.49. 0.35)
Years of age	37.3 ± 5.7	47.1 ± 9.0	44.5 ± 8.3	50.2 ± 10.0	0.0007***	1.29	0.01* (0.08, 0.25, 0.009, 0.87, 0.8, 0.33)	0.51 (0.37, 0.28, 0.5, 0.11, 0.14, 0.26)
HIV disease characteristics
Duration on ART regimen (months)	68.83 ± 48.05	75.74 ± 83.68	68.7 ± 57.93	31.2 ± 32.9	0.12	0.41	0.102 (0.51, 0.35, > 0.99, > 0.99, 0.66, 0.45)	0.37 (0.24, 0.17, 0.04, 0.10, 0.33, 0.24)
Plasma VL (log)	4.3 ± 1.61	3.8 ± 1.55	4.2 ± 1.61	3.4 ± 1.59	0.46	0.32	0.65 (0.91, 0.99, 0.66, 0.93, 0.94, 0.64)	0.21 (0.1, 0.03, 0.17, 0.09, 0.08, 0.18)
CD4 count	147.7 ± 239.01	142.8 ± 198.21	30.1 ± 35.81	122.1 ± 122.8	0.41	0.27	0.204 (0.99, 0.36, 0.98, 0.25, 0.99, 0.43)	0.29 (0.009, 0.23, 0.04, 0.25, 0.05, 0.21)